|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-3-9
|
|
pubmed:abstractText |
Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to approach that of the general population in some successfully treated subgroups. However, to attain these life expectancies, viral suppression must be maintained for decades.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1538-3679
|
|
pubmed:author |
pubmed-author:AntinoriAndreaA,
pubmed-author:CastagnaAntonellaA,
pubmed-author:ChêneGenèvieveG,
pubmed-author:CostagliolaDominiqueD,
pubmed-author:Cozzi-LepriAlessandroA,
pubmed-author:De LucaAndreaA,
pubmed-author:De WitStephaneS,
pubmed-author:DorrucciMariaM,
pubmed-author:DuvalXavierX,
pubmed-author:Fabre-ColinCélineC,
pubmed-author:GünthardHuldrychH,
pubmed-author:GarcíaFedericoF,
pubmed-author:GhosnJadeJ,
pubmed-author:JuddAliA,
pubmed-author:KjaerJesperJ,
pubmed-author:LedergerberBrunoB,
pubmed-author:Lo CaputoSergioS,
pubmed-author:LodwickRebeccaR,
pubmed-author:LundgrenJens DJD,
pubmed-author:MasipJoanJ,
pubmed-author:MasquelierBernardB,
pubmed-author:MeyerLaurenceL,
pubmed-author:MocroftAmandaA,
pubmed-author:MussiniCristinaC,
pubmed-author:ObelNielsN,
pubmed-author:Pérez-HoyosSantiagoS,
pubmed-author:ParaskevisDimitriosD,
pubmed-author:ParedesRogerR,
pubmed-author:PhillipsAndrew NAN,
pubmed-author:PillayDeenanD,
pubmed-author:PodzamczerDanielD,
pubmed-author:Pursuing Later Treatment Options II (PLATO II) Project Team for the...,
pubmed-author:RamosJoséJ,
pubmed-author:ReissPeterP,
pubmed-author:StaszewskiSchlomoS,
pubmed-author:TeiraRamónR,
pubmed-author:ThorneClaireC,
pubmed-author:TortiCarloC,
pubmed-author:TouloumiGiotaG,
pubmed-author:WarsawskiJosianeJ,
pubmed-author:van SighemArdA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
8
|
|
pubmed:volume |
170
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
410-9
|
|
pubmed:dateRevised |
2010-12-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20212176-Adolescent,
pubmed-meshheading:20212176-Adult,
pubmed-meshheading:20212176-Anti-HIV Agents,
pubmed-meshheading:20212176-Europe,
pubmed-meshheading:20212176-Female,
pubmed-meshheading:20212176-HIV Infections,
pubmed-meshheading:20212176-HIV Protease Inhibitors,
pubmed-meshheading:20212176-Humans,
pubmed-meshheading:20212176-Kaplan-Meier Estimate,
pubmed-meshheading:20212176-Life Expectancy,
pubmed-meshheading:20212176-Male,
pubmed-meshheading:20212176-Middle Aged,
pubmed-meshheading:20212176-Proportional Hazards Models,
pubmed-meshheading:20212176-Reverse Transcriptase Inhibitors,
pubmed-meshheading:20212176-Ritonavir,
pubmed-meshheading:20212176-Treatment Failure,
pubmed-meshheading:20212176-Viral Load,
pubmed-meshheading:20212176-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
